Servicios Personalizados
Revista
Articulo
Indicadores
Citado por SciELO
Accesos
Links relacionados
Citado por Google
Similares en SciELO
Similares en Google
Compartir
Iatreia
versión impresa ISSN 0121-0793
Resumen
GONZALEZ NARANJO, Luis Alonso; RESTREPO ESCOBAR, Mauricio y VASQUEZ DUQUE, Gloria María. Contraception in women with systemic erythematosus lupus. Iatreia [online]. 2013, vol.26, n.3, pp.313-324. ISSN 0121-0793.
The use of contraceptives, particularly of those containing estrogens by women with systemic lupus erythematosus (SLE), has been thought to carry risks such as disease exacerbation, thrombosis and other adverse effects. However, the available evidence suggests that many women with SLE, particularly those with stable disease, are not at increased risk of disease flare while taking oral contraceptives and therefore can be good candidates for most contraceptive methods, including the hormonal ones. Contrariwise, women with positive antiphospholipid antibodies are at increased risk of arterial and venous thrombosis and therefore the use of combined hormonal contraceptive methods should be avoided in them.
Palabras clave : Contraception; Systemic Lupus Erythematosus; Thrombosis.